New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For RAD;ODP;NAVB;AVEO;AMAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 26, 2015
16:01 EDTAMATOptions Update; March 26, 2015
Subscribe for More Information
06:00 EDTRADRite Aid implied volatility of 64 at upper end of index
Subscribe for More Information
March 25, 2015
07:32 EDTNAVBNavidea to present Lymphoseek injection data at SSO meeting
Navidea Biopharmaceuticals announced that data from its Lymphoseek injection studies in melanoma, breast and oral cavity squamous cell cancers will be presented at the 68th Annual Cancer Symposium of the Society of Surgical Oncology meeting held in Houston, TX, March 25-28. An oral presentation by Douglas Chepeha, M.D. of the University of Toronto-Princess Margaret Hospital reveals that analysis from Phase 3 data for detection of sentinel lymph nodes in head and neck oral cavity squamous cell carcinoma patients demonstrated high concordance between preoperative lymphoscintigraphy and intraoperative SLN biopsy findings. Notably, 95.2% of patients had agreement between their preoperative and intraoperative findings. This high concordance when using Lymphoseek confirms its role in the utility of preoperative lymphoscintigraphy imaging for planning and conducting SLN biopsy. Results of a follow-up outcome study presented as a poster by Julian Kim, M.D. of the University Hospitals Seidman Cancer Center indicated that in patients who were confirmed to be node-negative after sentinel lymph node biopsy the regional recurrence-free ratewas 98.8% at three years. An overall false negative rate for the two tumor types was 5.6% and the negative predictive value was 98.6%. These results demonstrate that Lymphoseek accurately identified SLNs and is likely predictive of pathological staging.
March 24, 2015
16:00 EDTAMATOptions Update; March 24, 2015
iPath S&P 500 VIX Short-Term Futures down 10c to 25.14 Option volume leaders: AAPL TSLA TWTR GILD FB AMAT GOOG C MRK GILD according to Track Data.
10:22 EDTRADRite Aid is ripe for a buyout, says Detwiler Fenton
Subscribe for More Information
08:12 EDTAMATApplied Materials April volatility elevated
Subscribe for More Information
March 23, 2015
11:26 EDTRADStocks with call strike movement; VALE RAD
Subscribe for More Information
06:07 EDTRADRite Aid implied volatility of 61 at upper end of index
March 22, 2015
16:42 EDTAMATChip equipment slowdown may not be as bad as first thought, WSJ says
Subscribe for More Information
March 20, 2015
06:09 EDTRADRite Aid implied volatility of 63 at upper end of index
March 19, 2015
16:01 EDTRAD, AMATOptions Update; March 19, 2015
Subscribe for More Information
11:02 EDTRADOptions with increasing implied volatility
Options with increasing implied volatility: HLF RAD NFLX HLSS NOW
09:37 EDTRADActive equity options trading on open
Subscribe for More Information
09:06 EDTODPCiti Retail Services extends long term consumer relationship with Office Depot
Subscribe for More Information
07:04 EDTRADAmerican Express confirms plans to launch Plenti loyalty program
Subscribe for More Information
05:49 EDTRADStocks with implied volatility movement; RAD XLV
Subscribe for More Information
March 18, 2015
16:00 EDTRADOptions Update; March 18, 2015
iPath S&P 500 VIX Short-Term Futures down 1.20 to 26.10. Option volume leaders: AAPL RAD PBR TWTR FB TSLA CLF BP MGM according to Track Data.
10:30 EDTRADRite Aid calls active on renewed takeover speculation
Rite Aid April 8 and 9 calls are active on 138K contracts (1K puts) on renewed takeover speculation. March call option implied volatility is at 72, April is at 62, May is at 53; compared to its 26-week average of 44 according to Track Data. Active call volume suggests traders taking positions for larger near term price movement.
10:15 EDTRADRumor: Rite Aid moves higher on renewed takeover speculation
Subscribe for More Information
06:16 EDTRADAmerican Express to launch Plenti loyalty program this spring, WSJ reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use